Firefly Neuroscience Expands Through Acquisition of Evoke

Firefly Neuroscience, an AI-driven company focusing on improving brain health outcomes, has announced its acquisition of Evoke Neuroscience, Inc., a provider of medical devices for brain health assessment. This acquisition is significant as it expands Firefly's proprietary database, intellectual property portfolio, and commercial reach significantly. Specifically, Firefly now hosts over 180,000 standardized EEG/ERP records, has secured 27 patents, and increased its commercial user base by 10-fold. The transaction was valued at $6 million, split equally between cash and Firefly stock. An additional earn-out of $500,000 in cash is contingent on performance milestones. This acquisition fortifies Firefly's strategy to establish a comprehensive model of the human brain using its FDA-approved Brain Network Analytics technology. With an extensive data set, enhanced technological synergies, and access to NVIDIA's advanced tools, Firefly continues to be on a path of rapid growth and innovation within the neurological health sector.